Naturally Splendid Enterprises Ltd. (
TSX-V.NSP,
OTCQB: NSPDF, FRA: 50N,
Forum) has announced the following update in regards to the Phase 2 Clinical Trial Application with Health Canada for a potential COVID-19 treatment. As an update to the Clinical Trial Application (CTA) process with Health Canada: A CTA was approved for submission to Health Canada on May 17, 2020.
Full article
here.
FULL DISCLOSURE:Naturally Splendid Enterprises Ltd. is a client of Stockhouse Publishing.